FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


140498 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
anti-D (Rh) immunglobulin 1500 IE, fyldt 2 ml sprøjte A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 1500 IEi fyldt injektionssprøjte A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 2500 IE injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 250 IE injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 5000 IE injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 5000 IE pulver og solvens til injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 5000iu powder for conventional release solution for injection vial A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 500 IE injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
anti-D (Rh) immunglobulin 600 IE pulver og solvens til injektionsvæske, opløsning, hætteglas A component that fails to comply with the current editorial guidance.
Anti-D (Rh) immunoglobulin 600iu powder for conventional release solution for injection vial A component that fails to comply with the current editorial guidance.
bivirkning af anti-D (Rh) immunglobulin Erroneous component (foundation metadata concept)
anti-D (Rh) immunglobulin injektionsvæske A component that fails to comply with the current editorial guidance.
Anti-D-antistoffer Ambiguous
Anti-D-globulin, ikke nærmere specificeret Erroneous component (foundation metadata concept)
Anti-D globulin NOS Erroneous component (foundation metadata concept)
anti-D-globulin givet Erroneous component (foundation metadata concept)
Anti-D globulin given Erroneous component (foundation metadata concept)
Anti-D globulin needed Erroneous component (foundation metadata concept)
behov for anti-D-globulin Erroneous component (foundation metadata concept)
Anti-D immunoglobulin given Erroneous component (foundation metadata concept)
Anti-D-immunglobulin givet Erroneous component (foundation metadata concept)
Anti-DNAse B antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-DNAse B antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-Hepatitis B immunoglobulin (& [given]) Ambiguous
Anti-IgA assay Ambiguous
Anti-Rabies immunoglobulin Ambiguous
Anti-T antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-T antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-Tetanus immunoglobulin (& injection) Ambiguous
allergi over for antiandrogener A component that fails to comply with the current editorial guidance.
Anti-brush border antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-cardiolipin antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-cardiolipin antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
forgiftning med forkølelsesmedicin, uvist med hvilken hensigt A component that fails to comply with the current editorial guidance.
Anti-criminal psychotherapy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-criminal psychotherapy NOS Classification derived component
Anti-criminal psychotherapy NOS Classification derived component
Anti-factor II disorder Ambiguous
overdosis af antacidum Ambiguous
Anti-gastric acid drug poisoning Ambiguous
Anti-gliadin IgA level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgA level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgA level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin IgG level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-gliadin antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
anti-gliadin IgA-antistofniveau A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
anti-gliadin IgG-antistofniveau A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
middel mod arthritis urica A component that is no longer current, useful, appropriate or acceptable.
Anti-haemoglobin antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
antidot mod heparin A component that fails to comply with the current editorial guidance.
Antiheparinmiddel A component that fails to comply with the current editorial guidance.
Anti-hepatitis B immunoglobulin given A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-hyaluronidase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-hyaluronidase assay Ambiguous
bivirkning af antiinfektiøse præparater opløsning til nasal anvendelse Ambiguous
allergi over for antiinfektiøse præparater til nasal anvendelse A component that fails to comply with the current editorial guidance.
Anti-infective nasal preps. A component that fails to comply with the current editorial guidance.
Anti-infective poisoning NOS Limited component (foundation metadata concept)
Anti-infective preparations A component that fails to comply with the current editorial guidance.
Anti-inflammat. light therapy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-inflammatory agent A component that fails to comply with the current editorial guidance.
Antiinflammatorisk middel A component that fails to comply with the current editorial guidance.
Anti-liver-kidney microsomal antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-myocardium antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nRNP antibody Ambiguous
Anti-neutrophil cytoplasmic antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-neutrophil cytoplasmic antibody negative A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear IgG antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear IgG antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear IgM antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear IgM antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear antibody measurement Ambiguous
Anti-nuclear factor level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear factor level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear factor level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear factor weakly positive A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear: ([factor] or [antibody] & level) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-nuclear: ([factor] or [antibody] & level) Ambiguous
Anti-phosphatidylglycerol antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-platelet prophylaxis Ambiguous
antitrombocytprofylakse Ambiguous
Anti-platelet prophylaxis Ambiguous
Anti-rabies immunoglobulin injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Antireumatisk middel A component that fails to comply with the current editorial guidance.
Anti-staph. haemolysin titre A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-streptokinase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-suicide psychotherapy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-suicide psychotherapy NOS Classification derived component
Anti-suicide psychotherapy NOS Classification derived component
Anti-tank personnel - Royal Marines Moved elsewhere
Anti-testes antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-tetanus immunoglobulin injection Ambiguous
Anti-tissue transglutaminase level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-tissue transglutaminase level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-tuberculous drug reaction A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-tuberculous drug reaction A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-varic-Zoster immunoglob (& injection) A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Anti-varic-Zoster immunoglob Ambiguous
Anti-varicella-zoster ig injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 117 of 1405 Next End


Reference Sets

Reference set descriptor

Back to Start